Logo image of PAH3.DE

PORSCHE AUTOMOBIL HLDG-PRF (PAH3.DE) Stock Fundamental Analysis

Europe - FRA:PAH3 - DE000PAH0038

34.22 EUR
+0.24 (+0.71%)
Last: 10/17/2025, 5:36:15 PM
Fundamental Rating

4

PAH3 gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 29 industry peers in the Automobiles industry. While PAH3 has a great health rating, its profitability is only average at the moment. PAH3 has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

PAH3 had negative earnings in the past year.
PAH3 had a positive operating cash flow in the past year.
PAH3 had positive earnings in 4 of the past 5 years.
PAH3 had a positive operating cash flow in each of the past 5 years.
PAH3.DE Yearly Net Income VS EBIT VS OCF VS FCFPAH3.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B -10B -15B -20B

1.2 Ratios

PAH3 has a Return On Assets of -43.36%. This is amonst the worse of the industry: PAH3 underperforms 89.66% of its industry peers.
The Return On Equity of PAH3 (-52.91%) is worse than 75.86% of its industry peers.
PAH3's Return On Invested Capital of 8.21% is fine compared to the rest of the industry. PAH3 outperforms 79.31% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for PAH3 is in line with the industry average of 7.07%.
The last Return On Invested Capital (8.21%) for PAH3 is above the 3 year average (6.04%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -43.36%
ROE -52.91%
ROIC 8.21%
ROA(3y)-9.78%
ROA(5y)-2.27%
ROE(3y)-12.42%
ROE(5y)-3.83%
ROIC(3y)6.04%
ROIC(5y)6.18%
PAH3.DE Yearly ROA, ROE, ROICPAH3.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40

1.3 Margins

With an excellent Operating Margin value of 99.28%, PAH3 belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Operating Margin of PAH3 has remained more or less at the same level.
The Profit Margin and Gross Margin are not available for PAH3 so they could not be analyzed.
Industry RankSector Rank
OM 99.28%
PM (TTM) N/A
GM N/A
OM growth 3Y-0.12%
OM growth 5Y0.3%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PAH3.DE Yearly Profit, Operating, Gross MarginsPAH3.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so PAH3 is still creating some value.
PAH3 has about the same amout of shares outstanding than it did 1 year ago.
PAH3 has about the same amout of shares outstanding than it did 5 years ago.
PAH3 has a worse debt/assets ratio than last year.
PAH3.DE Yearly Shares OutstandingPAH3.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
PAH3.DE Yearly Total Debt VS Total AssetsPAH3.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

PAH3 has an Altman-Z score of 1.95. This is not the best score and indicates that PAH3 is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 1.95, PAH3 belongs to the top of the industry, outperforming 86.21% of the companies in the same industry.
The Debt to FCF ratio of PAH3 is 5.28, which is a neutral value as it means it would take PAH3, 5.28 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 5.28, PAH3 is in the better half of the industry, outperforming 75.86% of the companies in the same industry.
PAH3 has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
PAH3's Debt to Equity ratio of 0.21 is amongst the best of the industry. PAH3 outperforms 86.21% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 5.28
Altman-Z 1.95
ROIC/WACC1.35
WACC6.1%
PAH3.DE Yearly LT Debt VS Equity VS FCFPAH3.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B 30B 40B 50B

2.3 Liquidity

PAH3 has a Current Ratio of 16.13. This indicates that PAH3 is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 16.13, PAH3 belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
A Quick Ratio of 16.13 indicates that PAH3 has no problem at all paying its short term obligations.
The Quick ratio of PAH3 (16.13) is better than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 16.13
Quick Ratio 16.13
PAH3.DE Yearly Current Assets VS Current LiabilitesPAH3.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

0

3. Growth

3.1 Past

PAH3 shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -494.45%.
Looking at the last year, PAH3 shows a very negative growth in Revenue. The Revenue has decreased by -34.13% in the last year.
Measured over the past years, PAH3 shows a decrease in Revenue. The Revenue has been decreasing by -5.37% on average per year.
EPS 1Y (TTM)-494.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-900.89%
Revenue 1Y (TTM)-34.13%
Revenue growth 3Y-9.48%
Revenue growth 5Y-5.37%
Sales Q2Q%-57.91%

3.2 Future

The Earnings Per Share is expected to grow by 7.23% on average over the next years.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-38.09%
EPS Next 2Y-2.55%
EPS Next 3Y2.1%
EPS Next 5Y7.23%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PAH3.DE Yearly Revenue VS EstimatesPAH3.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B
PAH3.DE Yearly EPS VS EstimatesPAH3.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PAH3. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 4.14, which indicates a rather cheap valuation of PAH3.
Based on the Price/Forward Earnings ratio, PAH3 is valued cheaply inside the industry as 93.10% of the companies are valued more expensively.
PAH3 is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.94, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 4.14
PAH3.DE Price Earnings VS Forward Price EarningsPAH3.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, PAH3 is valued cheaper than 82.76% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, PAH3 is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 3.66
EV/EBITDA 1.94
PAH3.DE Per share dataPAH3.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 -50 100 150 200

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.55%
EPS Next 3Y2.1%

6

5. Dividend

5.1 Amount

PAH3 has a Yearly Dividend Yield of 5.62%, which is a nice return.
PAH3's Dividend Yield is a higher than the industry average which is at 5.69.
Compared to an average S&P500 Dividend Yield of 2.36, PAH3 pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.62%

5.2 History

The dividend of PAH3 has a limited annual growth rate of 2.98%.
Dividend Growth(5Y)2.98%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

PAH3 has negative earnings and hence a negative payout ratio. The dividend may be in danger.
The dividend of PAH3 is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-4.22%
EPS Next 2Y-2.55%
EPS Next 3Y2.1%
PAH3.DE Yearly Income VS Free CF VS DividendPAH3.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B -10B -15B -20B

PORSCHE AUTOMOBIL HLDG-PRF

FRA:PAH3 (10/17/2025, 5:36:15 PM)

34.22

+0.24 (+0.71%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)08-13 2025-08-13
Earnings (Next)11-11 2025-11-11
Inst Owners15.72%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap5.24B
Analysts50.53
Price Target39.5 (15.43%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.62%
Yearly Dividend2.56
Dividend Growth(5Y)2.98%
DP-4.22%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.23%
PT rev (3m)-1.75%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.8%
EPS NY rev (3m)-31.77%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 4.14
P/S 1.04
P/FCF 3.66
P/OCF 3.66
P/B 0.15
P/tB 0.15
EV/EBITDA 1.94
EPS(TTM)-60.65
EYN/A
EPS(NY)8.26
Fwd EY24.14%
FCF(TTM)9.35
FCFY27.31%
OCF(TTM)9.35
OCFY27.31%
SpS32.75
BVpS229.28
TBVpS229.28
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -43.36%
ROE -52.91%
ROCE 11.66%
ROIC 8.21%
ROICexc 8.7%
ROICexgc 8.7%
OM 99.28%
PM (TTM) N/A
GM N/A
FCFM 28.53%
ROA(3y)-9.78%
ROA(5y)-2.27%
ROE(3y)-12.42%
ROE(5y)-3.83%
ROIC(3y)6.04%
ROIC(5y)6.18%
ROICexc(3y)6.21%
ROICexc(5y)6.32%
ROICexgc(3y)6.21%
ROICexgc(5y)6.33%
ROCE(3y)8.58%
ROCE(5y)8.78%
ROICexcg growth 3Y-8.5%
ROICexcg growth 5Y-7.91%
ROICexc growth 3Y-8.5%
ROICexc growth 5Y-7.78%
OM growth 3Y-0.12%
OM growth 5Y0.3%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 5.28
Debt/EBITDA 1.5
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 15.71
Cash Conversion 28.73%
Profit Quality N/A
Current Ratio 16.13
Quick Ratio 16.13
Altman-Z 1.95
F-Score4
WACC6.1%
ROIC/WACC1.35
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-494.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-900.89%
EPS Next Y-38.09%
EPS Next 2Y-2.55%
EPS Next 3Y2.1%
EPS Next 5Y7.23%
Revenue 1Y (TTM)-34.13%
Revenue growth 3Y-9.48%
Revenue growth 5Y-5.37%
Sales Q2Q%-57.91%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-34.28%
EBIT growth 3Y-9.59%
EBIT growth 5Y-5.09%
EBIT Next Year171.7%
EBIT Next 3Y25.41%
EBIT Next 5YN/A
FCF growth 1Y-23.64%
FCF growth 3Y25.04%
FCF growth 5Y14.85%
OCF growth 1Y-23.64%
OCF growth 3Y25.04%
OCF growth 5Y14.66%